Literature DB >> 23306724

The Royal College of Ophthalmologists' clinical guidelines for diabetic retinopathy: a summary.

F Ghanchi.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23306724      PMCID： PMC3574265          DOI： 10.1038/eye.2012.287

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  24 in total

1.  MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.

Authors:  Li-Li Qin; Mei-Xia An; Yan-Li Liu; Han-Chun Xu; Zhi-Qing Lu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

2.  Ophthalmologists' and patients' perspectives on treatments for diabetic retinopathy and maculopathy in Vietnam: a descriptive qualitative study.

Authors:  Katie Curran; Lynne Lohfeld; Nathan Congdon; Tunde Peto; Tung Thanh Hoang; Hue Thi Nguyen; Quan Nhu Nguyen; Van Thu Nguyen; Catherine Dardis; Hoang Tran; Hoang Huy Tran; Anh Tuan Vu; Mai Quoc Tung
Journal:  BMJ Open       Date:  2022-07-07       Impact factor: 3.006

Review 3.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

4.  Clinical Evaluation of Correlation Between Diabetic Retinopathy with Modifiable, Non-Modifiable and Other Independent Risk Factors in Tertiary Set-up in Central Rural India.

Authors:  Anjali P Shrote; Sachin Diagavane
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 5.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

6.  Risk factors for having diabetic retinopathy at first screening in persons with type 1 diabetes diagnosed under 18 years of age.

Authors:  James Rafferty; David R Owens; Stephen D Luzio; Patrick Watts; Ashley Akbari; Rebecca L Thomas
Journal:  Eye (Lond)       Date:  2020-12-01       Impact factor: 4.456

7.  Social deprivation as a risk factor for late presentation of proliferative diabetic retinopathy.

Authors:  Mark Lane; Priscilla A Mathewson; Hannah E Sharma; Helen Palmer; Peter Shah; Peter Nightingale; Marie D Tsaloumas; Alastair K Denniston
Journal:  Clin Ophthalmol       Date:  2015-02-17

8.  Triamcinolone as an adjunct to the combination of anti-VEGF for the management of diabetic macular edema.

Authors:  Ying-Ying Yu; Yong Cheng; Li-Bin Chang; Hui-Ka Xia; Xiao-Xin Li
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.645

Review 9.  Different lasers and techniques for proliferative diabetic retinopathy.

Authors:  Tanya Moutray; Jennifer R Evans; Noemi Lois; David J Armstrong; Tunde Peto; Augusto Azuara-Blanco
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.

Authors:  Huiyuan Hou; Chengyun Wang; Kaihui Nan; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-02       Impact factor: 4.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.